Abstract
Exogenous ochronosis is clinically and histologically similar to its endogenous counterpart; however, it exhibits no systemic effects and is not an inherited disorder. It is characterized by an asymptomatic hyperpigmentation of the face, sides and back of the neck, back, and extensor surfaces of the extremities. The associated ochronotic discoloration most commonly results from use of products containing hydroquinone. It also occurs following use of antimalarials and products containing resorcinol, phenol, mercury or picric acid. The etiology of hydroquinone-induced hyperpigmentation in exogenous ochronosis remains speculative.
The majority of patients with this condition are Black, but it has been reported to occur in Hispanics and Caucasians. Exogenous ochronosis is prevalent among South African Blacks, but is believed relatively uncommon within the US. The reasons for this phenomenon are not clear, but it could be a result of the use of skin care products containing resorcinol in combination with hydroquinone or the use of hydroquinone in a hydroalcoholic lotion.
Treatment of this condition is difficult. The offending agent must be avoided, but improvement occurs only slowly. A number of topical agents have been studied as have dermabrasion and the use of lasers. Controlled studies in larger numbers of patients are require to determine the true efficacy of newer treatments.
Similar content being viewed by others
References
Albers S, Brozena S., Glass L., et al. Alkaptonuria and ochronosis: case report and review. J Am Acad Dematol 1992; 27: 609–614
Offel J.V., DeClerck L., Francx L., et al. The clinical manifestations of ochronosis: a review. Acta Clin Belg 1995; 50: 358–362
Dom K., Pittevils T. Onchronotic arthropathy: the black hip. Case report and review of the literature. Acta Orthop Belg 1997; 63: 122–125
Hardwick N., Gelder L.V., Merwe C.V.D., et al. Exogenous ochronosis: an epidemiological study. Br J Dermatol 1989; 120: 229–238
Bruce S., Tschen J., Chow D. Exogenous ochronosis resulting from quinine injections. J Am Acad Dematol 1986; 15: 357–361
Touart D., Sau P. Cutaneous deposition diseases. Part II. J Am Acad Dermatol 1998; 39: 527–544
Kramer K., Lopez A., Stefanato C., et al. Exogenous ochronosis. J Am Acad Dermatol 2000; 42: 869–871
Lawrence N. Exogenous ochronosis in the United States. J Am Acad Dermatol 1988; 18: 1207–1211
Conner T., Braunstein B. Hyperpigmentation following the use of bleaching creams. Arch Dermatol 1987; 123: 105
Cullison D., Abele D., O’Quinn J. Localized exogenous ochronosis: report of a case and review of the literature. J Am Acad Dermatol 1983; 8: 882–889
Hoshaw R., Zimmerman K., Menter A. Ochronosis-like pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol 1985; 121: 105–108
Pennys N. Ochronosis-like pigmentation from hydroquinone bleaching creams [letter]. Arch Dermatol 1985; 121: 1239–1240
Fisher A.A. Tetracycline treatment for sarcoid-like ochronosis due to hydroquinone. Cutis 1988; 42: 19–20
Carey A.B., Park H.K., Burke W.A., et al. Bleaching cream associated exogenous ochronosis. Presented at the 26th Annual Meeting of the American Society of Dermatopathology, Washington (DC): USA. J Cutan Pathol 1988; 15: 299
Howard K., Furner B. Exogenous ochronosis in a mexican-american woman. Cutis 1990; 45: 180–182
Diven D., Smith E., Pupo R., et al. Hydroquinone-induced localized exogenous ochronosis treated with dermabrasion and CO2 laser. J Dermatol Surg Oncol 1990; 16: 1018–1022
Davis T.L., Trapp C.F., Grimwood R.E. Exogenous ochronosis occurring in a male Presented at the 28th Annual Meeting of the American Society of Dermatopathology, Atlanta, Georgia. J Cutan Pathol 1990; 17: 290
Jordaan H., Niekerk D.V. Transepidermal elimination in exogenous ochronosis. Am J Dermatopathol 1991; 13: 418–424
Martin R.F., Sanchez J.L., Gonzalez A., et al. Exogenous ochronosis. PR Health Sci J 1992; 11: 23–26
Snider R., Thiers B. Exogenous ochronosis. J Am Acad Dermatol 1993; 28: 662–664
Camarasa J.G., Serra-Baldrich E. Exogenous ochronosis with allergic contact dermatitis from hydroquinone. contact Derm 1994; 31: 57–58
Jacyk W. Annular granulomatous lesions in exogenous ochronosis are manifestation of sarcoidosis. Am J Dermatopathol 1995; 17: 18–22
Findlay G., Morrison J., Simson I. Exogenous ochronosis and pigmented colloid millium from hydroquinone bleaching creams. Br J Dermatol 1975; 93: 613–622
Schultz E., Summers B., Summers R. Inappropriate treatment of cosmetic ochronosis with hydroquinone. S Afr Med J 1988; 73: 59–60
Williams H. Skin lightening creams containing hydroquinone. BMJ 1992; 305: 903–904
Lang P. Probable coexisting exogenous ochronosis and mercurial pigmentation managed by dermabrasion. J Am Acad Dermatol 1988; 19: 942–946
Dogliotti M., Leibowitz M. Granulomatous ochronosis: a cosmetic-induced skin disorder in blacks. S Afr Med J 1979; 56: 757–760
Philips J., Isaacson C., Carman N. Ochronosis in black South Africans who used skin lighteners. Am J Dermatopathol 1986; 8: 14–21
Tidman M., Horton J., MacDonald D. Hydroquinone-induced ochronosis — light and electron microscopic features. Clin Exp Dermatol 1986; 11: 224–228
Burke P., Maibach H. Exogenous ochronosis: an overview. J Dermatol Treatmnt 1997; 8: 21–26
Findlay G., Beer H.D. Chronic hydroquinone poisoning of the skin from sun lightening cosmetics. S Afr Med J 1980; 57: 187–190
O’Donoghue M, Lynfield Y., Derbes V.. Ochronosis due to hydroquinone. J Am Acad Dermatol 1983; 8: 123
Engasser P., Maibach H. Cosmetics and dermatology: bleaching creams. J Am Acad Dermatol 1981; 5: 143–147
Thomas A., Gisburn M. Exogenous ochronosis and myxoedema from resorcinol. Br J Dermatol 1961; 73: 378–381
Kelly A., editor. Forum on hydroquinone induced ochronosis; 9 August 1987; Los Angeles (CA): USA [unpublished summary letter]
Bucks D., McMaster J., Guy R., et al. Percutaneous absorption of hydroquinone in humans: effect of 1-dodecylazacycloheptan-2-one (azone) and the 2-ethylhexyl ester of 4-(dimethylamino)benzoic acid (Escalol 507). J Toxicol Environ Health 1988; 24: 279–289
Chen Y., Chavin W. Hydroquinone activation and inhibition of skin tyrosinase, In: Riley V., editor. Proceedings of the 9th International Pigment Cell Conference; 1975 Jan 13–17; Houston (TX). New York: Karger Publishers, 1976: 105–112
Engasser P. Ochronosis caused by bleaching creams. J Am Acad Dermatol 1984; 10: 1072–1073
Hull P., Procter P. The melanocyte: an essential link in hydroquinone-induced ochronosis. J Am Acad Dermatol 1990; 22: 529–531
Shepartz B. Inhibition and activation of homogentisic acid. J Biol Chem 1953; 205: 185–192
Olumide Y., Odunowo B., Odiase A. Regional dermatoses in the African. Part I. Facial hypermelanosis. Int J Dermatol 1991; 30: 186–189
Briviba K., Devasagayam T.P., Sies H., et al. Selective para hydroxylation of phenol and aniline by singlet molecular oxygen. chem Res Toxicol 1993; 6 (4): 548–553
Kaufmann B., Wegmann W. Exogenous ochronosis after L-Dopa treatment. Pathologe 1992; 13: 164–166
Shultz E., Sher M. Rescinding of legislation to ban hydroquinone-containing bleaching creams. S Afr Med J 1990; 77: 372
Acknowledgements
We would like to thank Dr Eugene Gans who kindly critically reviewed this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Levin, C.Y., Maibach, H. Exogenous Ochronosis. Am J Clin Dermatol 2, 213–217 (2001). https://doi.org/10.2165/00128071-200102040-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200102040-00002